GlassScriptPhysician profile
Thomas J Whalen
NPI 1164587697
$1,888.33
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,822 · 2020: $47.90 · 2021: $18.23.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $280.71 | 2019-2020 | |
| Amgen INC. | $261.84 | 2019 | |
| Mallinckrodt Enterprises LLC | $226.87 | 2019 | |
| Celgene Corporation | $214.11 | 2019 | |
| Abbvie INC. | $204.06 | 2019 | |
| Genentech USA, INC. | $149.97 | 2019 | |
| Novartis Pharmaceuticals Corporation | $143.00 | 2019 | |
| Ucb, INC. | $65.73 | 2019 | |
| Lilly USA, LLC | $49.85 | 2019 | |
| Janssen Biotech, INC. | $47.16 | 2019 | |
| Collegium Pharmaceutical, INC. | $40.70 | 2019 | |
| Genzyme Corporation | $40.55 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $31.60 | 2019 | |
| Pacira Therapeutics, INC. | $30.88 | 2019 | |
| Sobi, INC | $29.53 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $21.84 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $18.23 | 2021 | |
| Scilex Pharmaceuticals INC. | $16.23 | 2019 | |
| Fidia Pharma USA INC. | $15.47 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Whalen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.